|
1
|
Gui H, Tong Q, Qu W, Mao CM and Dai SM:
The endocannabinoid system and its therapeutic implications in
rheumatoid arthritis. Int Immunopharmacol. 26:86–91. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kano M, Ohno-Shosaku T, Hashimotodani Y,
Uchigashima M and Watanabe M: Endocannabinoid-mediated control of
synaptic transmission. Physiol Rev. 89:309–380. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ligresti A, De Petrocellis L and Di Marzo
V: From phytocannabinoids to cannabinoid receptors and
endocannabinoids: Pleiotropic physiological and pathological roles
through complex pharmacology. Physiol Rev. 96:1593–1659. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cabral GA and Griffin-Thomas L:
Cannabinoids as therapeutic agents for ablating neuroinflammatory
disease. Endocr Metab Immune Disord Drug Targets. 8:159–172. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sugimoto N, Ishibashi H, Nakamura H,
Yachie A and Ohno-Shosaku T: Hypoxia-induced inhibition of the
endocannabinoid system in glioblastoma cells. Oncol Rep.
38:3702–3708. 2017.PubMed/NCBI
|
|
6
|
Joëls M: Corticosteroids and the brain. J
Endocrinol. 238:R121–R130. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brattsand R and Linden M: Cytokine
modulation by glucocorticoids: Mechanisms and actions in cellular
studies. Aliment Pharmacol Ther. 10 (Suppl 2):S81–S92. 1996.
View Article : Google Scholar
|
|
8
|
Wamsteeker JI, Kuzmiski JB and Bains JS:
Repeated stress impairs endocannabinoid signaling in the
paraventricular nucleus of the hypothalamus. J Neurosci.
30:11188–11196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leu H, Sugimoto N, Shimizu M, Toma T, Wada
T, Ohta K and Yachie A: Tumor necrosis factor-α modifies the
effects of Shiga toxin on glial cells. Int Immunopharmacol.
38:139–143. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sugimoto N, Miwa S, Nakamura H, Tsuchiya H
and Yachie A: Protein kinase A and Epac activation by cAMP
regulates the expression of glial fibrillary acidic protein in
glial cells. Arch Biol Sci. 68:795–801. 2016. View Article : Google Scholar
|
|
11
|
Solinas G and Becattini B: JNK at the
crossroad of obesity, insulin resistance, and cell stress response.
Mol Metab. 6:174–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ortega A, Rangel-López E, Hidalgo-Miranda
A, Morales A, Ruiz-García E, Meneses-García A, Herrera-Gómez A,
Aguilar-Ponce JL, González-Herrera IG, Guevara-Salazar P, et al: On
the effects of CP 55–940 and other cannabinoid receptor agonists in
C6 and U373 cell lines. Toxicol In Vitro. 29:1941–1951. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moreno-Smith M, Lutgendorf SK and Sood AK:
Impact of stress on cancer metastasis. Future Oncol. 6:1863–1881.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guindon J and Hohmann AG: The
endocannabinoid system and cancer: Therapeutic implication. Br J
Pharmacol. 163:1447–1463. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Klein TW: Cannabinoid-based drugs as
anti-inflammatory therapeutics. Nat Rev Immunol. 5:400–411. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Echigo R, Sugimoto N, Yachie A and
Ohno-Shosaku T: Cannabinoids inhibit peptidoglycan-induced
phosphorylation of NF-κB and cell growth in U87MG human malignant
glioma cells. Oncol Rep. 28:1176–1180. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gurley SN, Abidi AH, Allison P, Guan P,
Duntsch C, Robertson JH, Kosanke SD, Keir ST, Bigner DD, Elberger
AJ and Moore BM II: Mechanism of anti-glioma activity and in vivo
efficacy of the cannabinoid ligand KM-233. J Neurooncol.
110:163–177. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guzmán M: Cannabinoids: Potential
anticancer agents. Nat Rev Cancer. 3:745–755. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Salazar M, Carracedo A, Salanueva IJ,
Hernández-Tiedra S, Lorente M, Egia A, Vázquez P, Blázquez C,
Torres S, García S, et al: Cannabinoid action induces
autophagy-mediated cell death through stimulation of ER stress in
human glioma cells. J Clin Invest. 119:1359–1372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sarfaraz S, Adhami VM, Syed DN, Afaq F and
Mukhtar H: Cannabinoids for cancer treatment: Progress and promise.
Cancer Res. 68:339–342. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jang BC, Lim KJ, Suh MH, Park JG and Suh
SI: Dexamethasone suppresses interleukin-1beta-induced human
beta-defensin 2 mRNA expression: involvement of p38 MAPK, JNK,
MKP-1, and NF-kappaB transcriptional factor in A549 cells. FEMS
Immunol Med Microbiol. 51:171–184. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chantong B, Kratschmar DV, Nashev LG,
Balazs Z and Odermatt A: Mineralocorticoid and glucocorticoid
receptors differentially regulate NF-kappaB activity and
pro-inflammatory cytokine production in murine BV-2 microglial
cells. J Neuroinflammation. 9:2602012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang SS, Chen DZ, Wu H, Chen RC, Du SJ,
Dong JJ, Liang G, Xu LM, Wang XD, Yang YP, et al: Cannabinoid
receptors are involved in the protective effect of a novel curcumin
derivative C66 against CCl4-induced liver fibrosis. Eur J
Pharmacol. 779:22–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakatani Y, Amano T and Takeda H:
Corticosterone inhibits the proliferation of C6 glioma cells via
the translocation of unphosphorylated glucocorticoid receptor. Biol
Pharm Bull. 39:1121–1129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zoerner AA, Gutzki FM, Batkai S, May M,
Rakers C, Engeli S, Jordan J and Tsikas D: Quantification of
endocannabinoids in biological systems by chromatography and mass
spectrometry: A comprehensive review from an analytical and
biological perspective. Biochim Biophys Acta. 1811:706–723. 2011.
View Article : Google Scholar : PubMed/NCBI
|
